Speaker Profile
Founder & CEO, 23andMe Research Inst.
Biography
Anne Wojcicki is the founder and CEO of the 23andMe Research Institute. She is committed to putting individuals at the center of their health information and decisions with choice and transparency, and in turn empowering them to participate in research. Anne co-founded 23andMe, Inc. in 2006, three years after the first human genome was sequenced. Her goal was to help people access, understand, and benefit from the human genome and fundamentally change healthcare in the process. Prior to founding 23andMe, Anne spent a decade on Wall Street investing in healthcare and felt frustrated by a system built around monetizing illness instead of incentivizing prevention. Anne's vision and persistence powered an industry-first community approach to genetic research. This novel, web-based research model has resulted in thousands of new genetic discoveries and brought personalized medicine to millions of people.
Session Abstract – PMWC 2026 Silicon Valley
Track Chair:
Christina Curtis, Stanford
PMWC Award Ceremony
• W.E. Moerner, Stanford
• Serge Saxonov, 10x Genomics
• Priscilla Chan, Biohub
Honoree Fireside
• Christina Curtis, Stanford
• Priscilla Chan, Biohub
Honoree Fireside: From Measurement to Meaning: What Data AI Still Needs in Biology
• Christina Curtis, Stanford
• W.E. Moerner, Stanford
• Serge Saxonov, 10x Genomics
Unraveling Tissue Architecture with Single-Cell & Spatial Multi-Omics
• Chair: Garry P. Nolan, Stanford
• Joakim Lundeberg, SciLifeLab
• Tae Hyun Hwang, Vanderbilt University Medical Center
• Michael Angelo, Stanford
Spatial Sequencing for Next Generation Pathology
• Eli Glezer, Singular Genomics
Precision Profiling of Cells: Insights from Imaging-Spectral Flow Cytometry and Single-Cell Multiomics
• Aruna Ayer, BD
Single-Cell Genotype and Targeted Gene Expression Assay
• Zivjena Vucetic, Mission Bio
Resolving Cellular Lineage and State in Tumors with High-Resolution Single-Cell Genomics
• Gary Schroth, Cellanome
From Cellular State to Disease Gene Prediction at Population Scale
• Kyle Farh, Illumina
Tumor Evolution & Clonal Dynamics: From Models to Monitoring
• Christina Curtis, Stanford
Personal Omics at Scale: What Longitudinal Profiles Add to Early Detection
• Michael Snyder, Stanford
Multi-Omics-Driven Early Detection: Beyond Liquid Biopsy
• Chair: Alex Aravanis, Moonwalk Biosciences
• Ash Alizadeh, Stanford
• Sara Ahadi, OmicsEra
AI in Molecular Diagnostics: Integrating Multi-Omics & Clinical Data
• Chair: Marina Sirota, UCSF
• Olivier Gevaert, Stanford
• Rebecca Critchley-Thorne, Castle Biosciences
• Lihua Jiang, Stanford
• Yunguan Wang, Cincinnati Children's
